Rankings
▼
Calendar
HRTX FY 2008 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HRTX
Heron Therapeutics, Inc.
$147M
FY 2008 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$369,000
-10.4% YoY
Gross Profit
$369,000
100.0% margin
Operating Income
-$23M
-6353.7% margin
Net Income
-$23M
-6266.9% margin
EPS (Diluted)
$-15.00
Cash Flow
Operating Cash Flow
-$24M
Free Cash Flow
-$25M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$12M
Total Liabilities
$4M
Stockholders' Equity
$8M
Cash & Equivalents
$10M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$369,000
$412,000
-10.4%
Gross Profit
$369,000
$412,000
-10.4%
Operating Income
-$23M
-$24M
+0.8%
Net Income
-$23M
-$20M
-14.7%
← FY 2007
All Quarters
FY 2009 →